Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Deerfield Management

James E. Flynn

2,163,554 $51,839 +113% 0.92%
2.
RA Capital Management

Peter Kolchinsky

1,930,322 $46,251 +452% 0.74%
3.
Vivo Capital

Albert Cha And Frank Kung

1,863,296 $44,645 1.93%
4. 1,191,101 $28,539 +25% 0.42%
5.
Adage Capital Management

Phill Gross And Robert Atchinson

885,000 $21,205 +10% 0.04%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.34 47,431 Director 1,138,179 2020-10-30 Filing
$17.17 68,255 Director 1,090,748 2020-10-30 Filing
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.18 10,000 Officer, Director 124,670 2021-10-01 Filing
$20.52 5,000 Officer 37,969 2021-08-02 Filing
$20.52 6,000 Officer 8,234 2021-08-02 Filing
$24.35 5,650 Officer, Director 134,670 2021-07-01 Filing
$23.88 4,350 Officer, Director 140,320 2021-07-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 45 $1 0%
2. 0 $0 0%
3. 0 $0 0%
4. 0 $0 0%
News See All